Morgan Stanley’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$155K Buy
+7,658
New +$202K ﹤0.01% 6118

Other funds holding BRVE

Morgan Stanley's BRVE Position: Q3 2026 in Review

Morgan Stanley opened a new position in Braveheart Bio (BRVE) in Q3 2026: 7,658 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #6118 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • Morgan Stanley held 7,658 shares of Braveheart Bio worth $155K as of Q3 2026.
  • Braveheart Bio was a new Morgan Stanley position in Q3 2026.
  • Braveheart Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6118 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.